P282 Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.